Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals

Journal of the American Society of Nephrology

Volumn 15, Issue 12, 2004, Pages 3184-3191

  Fried, Linda ^a,i   Solomon, Cam ^b   Shlipak, Michael ^c   Seliger, Stephen ^d   Stehman Breen, Catherine ^d,e   Bleyer, Anthony J ^f   Chaves, Paolo ^g   Furberg, Curt ^f   Kuller, Lewis ^h   Newman, Anne ^a,h  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; HEMOGLOBIN; LIPID;

AGE; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOCYTE COUNT; LINEAR REGRESSION ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SMOKING;

EID: 9644287895     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000146422.45434.35     Document Type: Article

References (28)

1. Kasiske BL: Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 31: 1153-1159, 1987
2. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39[Suppl 31]: S29-S34, 1991
3. Ross R: Atherosclerosis, an inflammatory disease. N Engl J Med 340: 115-126, 1999
4. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and pro-coagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92, 2003
5. Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG: Tobacco, hypertension and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 57: 2072-2079, 2000
6. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263-276, 1991
7. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J: Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5: 270-277, 1995
8. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP: Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41: 264-270, 1995
9. Mittelmark MB, Psaty BM, Rautaharju PM, Fried LP, Borhani NO, Tracy RP, Gardin JM, O'Leary DH, for the Cardiovascular Health Study Collaborative Research Group: Prevalence of cardiovascular diseases among older adults in the Cardiovascular Health Study. Am J Epidemiol 137: 311-317, 1993
10. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification: Evaluation of laboratory measurements for clinical assessment of kidney disease. Am J Kidney Dis 40[Suppl 1]: S76-S111, 2002
11. Klein R, Klein BEK, Moss SE, Cruickshanks KJ, Brazy PC: The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 22: 743-751, 1999
12. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 18: 499-501, 1972
13. Macy EM, Hayes TE, Tracy RP: Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin Chem 43: 52-58, 1997
14. Gardin JM, Wong ND, Bommer W, Klopfenstein HS, Smith VE, Tabatznik B, Siscovick D, Lobodzinski S, Anton-Culver H, Manolio TA: Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr 5: 63-72, 1992
15. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O'Leary D, Psaty B, Robbins J: Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 139: 1164-1179, 1994
16. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA: Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 22: 1155-1163, 1991
17. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals, J Am Coll Cardiol 41: 1364-1372, 2003
18. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcvina SM, Greene T, Levey AS: Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62: 2208-2215, 2002
19. Erlinger TP, Tarver-Carr ME, Powe NR, Appel LJ, Coresh J, Eberhardt MS, Brancati FL: Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US Adults. Am J Kidney Dis 42: 256-263, 2003
20. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis D: Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Kidney Int 62: 963-970, 2002
21. U.S. Renal Data System: 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2003
22. Ueda H, Ishimura E, Shoji T, Emoto M, Morioka T, Matsumoto N, Fukumoto S, Miki T, Inaba M, Nishizawa Y: Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 26: 1530-1534, 2003
23. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33: 63-72, 1999
24. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S, Shapira I, Laniado S, Iaina A: The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37: 1775-1780, 2001
25. Ruggenenti P, Perna A, Remuzzi G, for the GISEN Group Investigators. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. Kidney Int 63: 2254-2261, 2003
26. Yu HT: Progression of chronic renal failure. Arch Intern Med 163: 1417-1429, 2003
27. Levey AS, Gassman JJ, Hall PM, Walker EG for the Modification of Diet in Renal Disease (MDRD) Study Group: Assessing the progression of renal disease in clinical studies: Effects of duration of follow-up and regression to the mean. J Am Soc Nephrol 1: 1087-1094, 1991
28. Collins AJ, Li S, Gilbertson DT, Liu J, Chen S-C, Herzog CA: Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 64[Suppl 87]: S24-S31, 2003